Founded on deep pharmaceutical expertise, Worldwide Compliance has guided hundreds of organizations through the complexities of global regulatory submissions — from first DMF to full market authorization.
Worldwide Compliance was established by regulatory affairs professionals with direct experience inside pharmaceutical manufacturing and regulatory agencies. That insider perspective — understanding what regulators look for and what manufacturers need — is the foundation of everything we do.
Over 30 years, we have built a reputation for technical depth, meticulous documentation, and an unwavering commitment to getting submissions right the first time. Our clients range from emerging API manufacturers entering the U.S. market for the first time to established multinational pharmaceutical companies managing complex global portfolios.
We go beyond surface-level compliance. Our team engages with the science — impurity profiles, synthesis routes, stability data — to build defensible, technically rigorous dossiers.
Every submission we prepare reflects the current expectations of FDA, EMA, and ICH. We track evolving guidance and apply it proactively, not reactively.
We work as an extension of your regulatory team — not as a vendor. Your timelines, your challenges, and your success are our shared responsibility.
From FDA submissions in Washington to EMA filings in Amsterdam and ASEAN dossiers across Southeast Asia — we operate across every major regulatory jurisdiction.
We operate across every major pharmaceutical regulatory jurisdiction — bringing the same level of precision and technical depth whether you're filing with the FDA, EMA, EDQM, or ASEAN authorities.
Whether you need a single DMF prepared or a full regulatory strategy across multiple markets — we have the expertise and the track record to deliver.